Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients
ConclusionRetreatment with OXA in CRC patients is a feasible option even in patients who previously developed moderate or severe OIN. One-third of patients ’ OIN was worsened by retreatment. Neurological monitoring should be considered.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Eloxatin | Neurology | Peripheral Neuropathy | Study | Toxicology